www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Anti-PD-1 (Toripalimab), Humanized Antibody

Supplier:
Catalogue number:
A2161-100
Size:
100 µg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£581.00 Estimated delivery Wed 23 Jun
Shipping is calculated in checkout

The research-grade biosimilar is a humanised IgG4 recombinant monoclonal antibody that binds to programmed death receptor-1 (PD-1) and prevents the interaction with its ligands PD-L1 and PD-L2. This results in the activation of T-cell mediated immune response and inhibits tumor cell growth. The original drug received approval in China in 2018 as the second line of treatment for melanoma. Currently, the drug is evaluated for efficacy and toxicity in Phase I-III clinical trials for nasopharyngeal carcinoma, head and neck squamous cell carcinoma and gastric adenocarcinoma

Product Type:

Antibodies

Species Reactivity:

Human

Storage Temp:

-80°C

Antibody Host:

Recombinant

Antibody Isotype:

IgG4, kappa

Formulation:

In PBS, pH 7.5

Antibody Type:

Monoclonal

UNSPSC Code:

12352203

Details Cat number & supplier Size Price
Anti-IGF-1R (Teprotumumab), Human IgG1 Antibody A2160-100 · BioVision
A2160-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-5Rα (Benralizumab), Humanized Antibody A2162-100 · BioVision
A2162-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL-23α (Tildrakizumab), Humanized Antibody A2159-100 · BioVision
A2159-100
BioVision
100 µg £581.00
100 µg
view
Anti-CTLA-4 (Tremelimumab), Human IgG2 Antibody A2163-100 · BioVision
A2163-100
BioVision
100 µg £581.00
100 µg
view
Anti-IL5 (Mepolizumab), Humanized Antibody A2158-100 · BioVision
A2158-100
BioVision
100 µg £581.00
100 µg
view
Anti-CD6 (Itolizumab), Humanized Antibody A2164-100 · BioVision
A2164-100
BioVision
100 µg £581.00
100 µg
view
Anti-BRCA1 Antibody A2157-100 · BioVision
A2157-100
BioVision
100 µl £435.00
100 µl
view